The authors have designated this AOP as all rights reserved. Re-use in any form requires advanced permission from the authors.

AOP: 647

Title

A descriptive phrase which references both the Molecular Initiating Event and Adverse Outcome.It should take the form “MIE leading to AO”. For example, “Aromatase inhibition leading to reproductive dysfunction” where Aromatase inhibition is the MIE and reproductive dysfunction the AO. In cases where the MIE is unknown or undefined, the earliest known KE in the chain (i.e., furthest upstream) should be used in lieu of the MIE and it should be made clear that the stated event is a KE and not the MIE.  More help

ROS formation leading to growth inhibition modulated by the Keap1–Nrf2 antioxidant response

Short name
A name that succinctly summarises the information from the title. This name should not exceed 90 characters. More help
ROS leading to growth inhibition moduleated by the Keap1–Nrf2 antioxidant response
The current version of the Developer's Handbook will be automatically populated into the Handbook Version field when a new AOP page is created.Authors have the option to switch to a newer (but not older) Handbook version any time thereafter. More help
Handbook Version v2.8

Graphical Representation

A graphical representation of the AOP.This graphic should list all KEs in sequence, including the MIE (if known) and AO, and the pair-wise relationships (links or KERs) between those KEs. More help
Click to download graphical representation template Explore AOP in a Third Party Tool

Authors

The names and affiliations of the individual(s)/organisation(s) that created/developed the AOP. More help

Ying Wang1, Li Xie2

1. Research Institute of Aero-Engine, Beihang University, 37 Xueyuan Road, Beijing, China

2. Norwegian Institute for Water Research (NIVA), Sognsveien 72, OSLO, Norway.

Point of Contact

The user responsible for managing the AOP entry in the AOP-KB and controlling write access to the page by defining the contributors as described in the next section.   More help
Ying Wang   (email point of contact)

Contributors

Users with write access to the AOP page.  Entries in this field are controlled by the Point of Contact. More help
  • Ying Wang
  • Li Xie

Coaches

This field is used to identify coaches who supported the development of the AOP.Each coach selected must be a registered author. More help

OECD Information Table

Provides users with information concerning how actively the AOP page is being developed and whether it is part of the OECD Workplan and has been reviewed and/or endorsed. OECD Project: Assigned upon acceptance onto OECD workplan. This project ID is managed and updated (if needed) by the OECD. OECD Status: For AOPs included on the OECD workplan, ‘OECD status’ tracks the level of review/endorsement of the AOP . This designation is managed and updated by the OECD. Journal-format Article: The OECD is developing co-operation with Scientific Journals for the review and publication of AOPs, via the signature of a Memorandum of Understanding. When the scientific review of an AOP is conducted by these Journals, the journal review panel will review the content of the Wiki. In addition, the Journal may ask the AOP authors to develop a separate manuscript (i.e. Journal Format Article) using a format determined by the Journal for Journal publication. In that case, the journal review panel will be required to review both the Wiki content and the Journal Format Article. The Journal will publish the AOP reviewed through the Journal Format Article. OECD iLibrary published version: OECD iLibrary is the online library of the OECD. The version of the AOP that is published there has been endorsed by the OECD. The purpose of publication on iLibrary is to provide a stable version over time, i.e. the version which has been reviewed and revised based on the outcome of the review. AOPs are viewed as living documents and may continue to evolve on the AOP-Wiki after their OECD endorsement and publication.   More help
OECD Project # OECD Status Reviewer's Reports Journal-format Article OECD iLibrary Published Version
This AOP was last modified on August 20, 2026 08:44

Revision dates for related pages

Page Revision Date/Time
Increase, Reactive oxygen species June 12, 2025 01:27
Increase, Cell injury/death May 27, 2024 07:23
Increase, Oxidative Stress February 11, 2026 07:05
Increase, Lipid peroxidation June 23, 2026 06:46
Increase, Protein oxidation June 23, 2026 06:29
Decrease, Growth July 06, 2022 07:36
Increase, Cytochrome c release November 02, 2020 05:57
Increase, Endoplasmic reticulum stress February 11, 2026 06:00
Activation, caspases September 14, 2023 08:35
Increase, ROS leads to Increase, Oxidative Stress June 23, 2026 06:57
Increase, Oxidative Stress leads to Increase, LPO June 23, 2026 06:59
Increase, Oxidative Stress leads to Increase, Protein oxidation June 23, 2026 07:04
Increase, LPO leads to Increase, Cyt c release August 20, 2026 08:05
Increase, Protein oxidation leads to Increase, ER stress August 20, 2026 08:05
Increase, Cyt c release leads to Caspase activation September 14, 2023 09:02
Increase, ER stress leads to Caspase activation August 20, 2026 08:05
Cell injury/death leads to Decrease, Growth June 23, 2026 07:54
Caspase activation leads to Cell injury/death August 20, 2026 08:06
Silver nanoparticles February 15, 2017 03:19

Abstract

A concise and informative summation of the AOP under development that can stand-alone from the AOP page. The aim is to capture the highlights of the AOP and its potential scientific and regulatory relevance. More help

This AOP describes the linkage between increased reactive oxygen species (ROS) formation and decreased organismal growth. The molecular initiating event is increased ROS formation. When ROS production exceeds the buffering capacity of endogenous antioxidant systems, oxidative stress increases. This oxidative burden leads to oxidative damage to cellular macromolecules through two key-event branches: increased lipid oxidation and increased protein oxidation. Increased lipid and protein oxidation can disrupt cellular homeostasis and contribute to mitochondrial and endoplasmic-reticulum stress responses. These processes are represented by increased cytochrome c release and increased endoplasmic-reticulum stress, which promote increased caspase activation. Caspase activation contributes to increased cell injury and cell death. At the organism level, cumulative cellular injury and loss of viable or functional cells can result in decreased growth. The Keap1-Nrf2 antioxidant response is included as a modulating component of this AOP. ROS-mediated modification of Keap1 cysteine residues promotes Nrf2 nuclear accumulation and induction of antioxidant enzymes. This adaptive response can reduce oxidative stress and influence the threshold, magnitude and progression of downstream key events. This AOP provides a mechanistic framework for linking ROS formation, oxidative macromolecular damage, stress-response signalling, apoptotic activation, cell injury and growth impairment. It is considered broadly applicable across aerobic eukaryotes because ROS formation, oxidative damage, antioxidant defence and regulated cell-death processes are conserved biological features. Growth impairment is included as the adverse outcome because it is a biologically and ecotoxicologically relevant endpoint across multiple taxa.

AOP Development Strategy

Context

Used to provide background information for AOP reviewers and users that is considered helpful in understanding the biology underlying the AOP and the motivation for its development.The background should NOT provide an overview of the AOP, its KEs or KERs, which are captured in more detail below. More help

Reactive oxygen species (ROS) are produced during normal aerobic metabolism and act as physiological signalling molecules. Their biological effects depend on concentration, duration, cellular location and antioxidant capacity. At controlled levels, ROS participate in redox regulation; when ROS production exceeds antioxidant and repair capacity, oxidative stress can disrupt redox signalling and damage cellular macromolecules (Sies and Jones, 2020; Sies, 2015). In aquatic animals, environmentally induced oxidative stress is a common response to chemical and non-chemical stressors, including metals, pesticides, nanoparticles, radiation and changes in environmental conditions (Lushchak, 2011; Song et al., 2023). 

Cells maintain redox homeostasis through antioxidant enzymes, low-molecular-weight redox buffers and stress-response pathways. The Keap1-Nrf2 pathway is a major adaptive defence system against oxidative and electrophilic stress. Keap1 represses Nrf2-dependent activation of antioxidant response elements under basal conditions, while oxidative or electrophilic modification of Keap1 promotes Nrf2 activation and induction of antioxidant and detoxification genes (Itoh et al., 1999; Baird and Yamamoto, 2020). This adaptive response is important for interpreting oxidative-stress outcomes because it can delay, reduce or modify downstream toxicity depending on exposure intensity, duration and biological capacity for compensation. Sustained oxidative stress can affect cell fate through damage to lipids, proteins and other macromolecules, and through interactions with mitochondrial and endoplasmic-reticulum (ER) stress responses. Cytochrome c has a central role in mitochondrial apoptosis, including cardiolipin oxidation and release of proapoptotic factors, followed by Apaf-1/caspase-9 complex formation and activation of the apoptotic protease cascade (Kagan et al., 2005; Li et al., 1997). ER stress is also linked to cell-fate decisions and can contribute to apoptosis when adaptive unfolded-protein responses are insufficient (Cao and Kaufman, 2014; Chen et al., 2023).

Growth impairment is a regulatory and ecotoxicologically relevant apical outcome because growth integrates energy acquisition, metabolism, cellular proliferation, tissue maintenance and development over time. Previous work on AOP development for chronic toxicity has used growth impairment to illustrate how mechanistic information can support interpretation of adverse outcomes relevant to hazard assessment (Groh et al., 2015). The present AOP was developed to organise conserved oxidative-stress biology in a form useful for mechanistic interpretation, chemical prioritisation and future integrated approaches to testing and assessment.

Strategy

Provides a description of the approaches to the identification, screening and quality assessment of the data relevant to identification of the key events and key event relationships included in the AOP or AOP network.This information is important as a basis to support the objective/envisaged application of the AOP by the regulatory community and to facilitate the reuse of its components.  Suggested content includes a rationale for and description of the scope and focus of the data search and identification strategy/ies including the nature of preliminary scoping and/or expert input, the overall literature screening strategy and more focused literature surveys to identify additional information (including e.g., key search terms, databases and time period searched, any tools used). More help

Summary of the AOP

This section is for information that describes the overall AOP.The information described in section 1 is entered on the upper portion of an AOP page within the AOP-Wiki. This is where some background information may be provided, the structure of the AOP is described, and the KEs and KERs are listed. More help

Events:

Molecular Initiating Events (MIE)
An MIE is a specialised KE that represents the beginning (point of interaction between a prototypical stressor and the biological system) of an AOP. More help
Key Events (KE)
A measurable event within a specific biological level of organisation. More help
Adverse Outcomes (AO)
An AO is a specialized KE that represents the end (an adverse outcome of regulatory significance) of an AOP. More help
Type Event ID Title Short name
MIE 1115 Increase, Reactive oxygen species Increase, ROS
KE 1392 Increase, Oxidative Stress Increase, Oxidative Stress
KE 1445 Increase, Lipid peroxidation Increase, LPO
KE 1767 Increase, Protein oxidation Increase, Protein oxidation
KE 55 Increase, Cell injury/death Cell injury/death
KE 1812 Increase, Cytochrome c release Increase, Cyt c release
KE 1815 Increase, Endoplasmic reticulum stress Increase, ER stress
KE 2188 Activation, caspases Caspase activation
AO 1521 Decrease, Growth Decrease, Growth

Relationships Between Two Key Events (Including MIEs and AOs)

This table summarizes all of the KERs of the AOP and is populated in the AOP-Wiki as KERs are added to the AOP.Each table entry acts as a link to the individual KER description page. More help

Network View

This network graphic is automatically generated based on the information provided in the MIE(s), KEs, AO(s), KERs and Weight of Evidence (WoE) summary tables. The width of the edges representing the KERs is determined by its WoE confidence level, with thicker lines representing higher degrees of confidence. This network view also shows which KEs are shared with other AOPs. More help

Prototypical Stressors

A structured data field that can be used to identify one or more “prototypical” stressors that act through this AOP. Prototypical stressors are stressors for which responses at multiple key events have been well documented. More help

Life Stage Applicability

The life stage for which the AOP is known to be applicable. More help
Life stage Evidence
Not Otherwise Specified High

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) can be selected.In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available. More help
Term Scientific Term Evidence Link
fish fish High NCBI
crustaceans Daphnia magna Moderate NCBI

Sex Applicability

The sex for which the AOP is known to be applicable. More help
Sex Evidence
Unspecific High

Overall Assessment of the AOP

Addressess the relevant biological domain of applicability (i.e., in terms of taxa, sex, life stage, etc.) and Weight of Evidence (WoE) for the overall AOP as a basis to consider appropriate regulatory application (e.g., priority setting, testing strategies or risk assessment). More help

Domain of Applicability

Addressess the relevant biological domain(s) of applicability in terms of sex, life-stage, taxa, and other aspects of biological context. More help

Essentiality of the Key Events

The essentiality of KEs can only be assessed relative to the impact of manipulation of a given KE (e.g., experimentally blocking or exacerbating the event) on the downstream sequence of KEs defined for the AOP. Consequently, evidence supporting essentiality is assembled on the AOP page, rather than on the independent KE pages that are meant to stand-alone as modular units without reference to other KEs in the sequence. The nature of experimental evidence that is relevant to assessing essentiality relates to the impact on downstream KEs and the AO if upstream KEs are prevented or modified. This includes: Direct evidence: directly measured experimental support that blocking or preventing a KE prevents or impacts downstream KEs in the pathway in the expected fashion. Indirect evidence: evidence that modulation or attenuation in the magnitude of impact on a specific KE (increased effect or decreased effect) is associated with corresponding changes (increases or decreases) in the magnitude or frequency of one or more downstream KEs. More help

Evidence Assessment

Addressess the biological plausibility, empirical support, and quantitative understanding from each KER in an AOP. More help

Known Modulating Factors

Modulating factors (MFs) may alter the shape of the response-response function that describes the quantitative relationship between two KES, thus having an impact on the progression of the pathway or the severity of the AO.The evidence supporting the influence of various modulating factors is assembled within the individual KERs. More help
Modulating Factor (MF) Influence or Outcome KER(s) involved
     

Quantitative Understanding

Optional field to provide quantitative weight of evidence descriptors.  More help

Considerations for Potential Applications of the AOP (optional)

Addressess potential applications of an AOP to support regulatory decision-making.This may include, for example, possible utility for test guideline development or refinement, development of integrated testing and assessment approaches, development of (Q)SARs / or chemical profilers to facilitate the grouping of chemicals for subsequent read-across, screening level hazard assessments or even risk assessment. More help

References

List of the literature that was cited for this AOP. More help

Chen, X., Shi, C., He, M., Xiong, S., & Xia, X. (2023). Endoplasmic reticulum stress: Molecular mechanism and therapeutic targets. Signal Transduction and Targeted Therapy, 8, 352. https://doi.org/10.1038/s41392-023-01570-w

Groh, K. J., Carvalho, R. N., Chipman, J. K., Denslow, N. D., Halder, M., Murphy, C. A., Roelofs, D., Rolaki, A., Schirmer, K., & Watanabe, K. H. (2015). Development and application of the adverse outcome pathway framework for understanding and predicting chronic toxicity: II. A focus on growth impairment in fish. Chemosphere, 120, 778-792. https://doi.org/10.1016/j.chemosphere.2014.10.006

Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999). Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes & Development, 13(1), 76-86. https://doi.org/10.1101/gad.13.1.76

Kagan, V. E., Tyurin, V. A., Jiang, J., Tyurina, Y. Y., Ritov, V. B., Amoscato, A. A., Osipov, A. N., Belikova, N. A., Kapralov, A. A., Kini, V., Vlasova, I. I., Zhao, Q., Zou, M., Di, P., Svistunenko, D. A., Kurnikov, I. V., & Borisenko, G. G. (2005). Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nature Chemical Biology, 1(4), 223-232. https://doi.org/10.1038/nchembio727

Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91(4), 479-489. https://doi.org/10.1016/S0092-8674(00)80434-1

Lushchak, V. I. (2011). Environmentally induced oxidative stress in aquatic animals. Aquatic Toxicology, 101(1), 13-30. https://doi.org/10.1016/j.aquatox.2010.10.006

Sies, H. (2015). Oxidative stress: A concept in redox biology and medicine. Redox Biology, 4, 180-183. https://doi.org/10.1016/j.redox.2015.01.002

Sies, H., & Jones, D. P. (2020). Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nature Reviews Molecular Cell Biology, 21(7), 363-383. https://doi.org/10.1038/s41580-020-0230-3

Song, C., Sun, C., Liu, B., & Xu, P. (2023). Oxidative stress in aquatic organisms. Antioxidants, 12(6), 1223. https://doi.org/10.3390/antiox12061223